New Plot Details & Leaks About All Upcoming Movies & Disney Plus Shows. I discuss Black Widow, Thor Love And Thunder, ...

Acrivon Therapeutics (ACRV) will be providing ACR-368 and ACR-2316 clinical data and other updates via a press release at 7:30 a.m. ET, and ...

SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

ProKidney (NASDAQ:PROK) said Monday that it has appointed a new CEO and plans to update its Phase 3 development program for its cell therapy REACT to focus on patients with advanced chronic kidney ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Phase 3 EVOKE-01 study did not meet its primary endpoint of overall survival (OS) in previously ...

SAN DIEGO, Dec. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine ...

Acurx (ACXP) Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA communications. Acurx’s Executive Chairman, Bob DeLuccia, ...

Esther Rajavelu appointed Interim CEO; Frank Thomas becomes Chairman amid SEC Wells Notice response; Phase 3 trial enrollment exceeds 60%. Spero Therapeutics announced leadership changes, appointing ...

Mutuum Finance (MUTM) is a new crypto project focused on decentralized lending and borrowing. As of its latest update, the ...